P121 MMP-7 is a predictive biomarker of disease progression in patients with early diagnosis of Idiopathic Pulmonary Fibrosis.

The heterogeneity of disease progression in the IPF patient population poses significant obstacles to offer optimal patient care and prevents efficient development of novel therapeutic interventions. Disease-relevant biomarkers could enable more accurate prognostication, as well as patient stratification for drug developmentand personalized …